News

The new SphygmoCor offers improvements to simplify clinical use, and will assist evaluation of cardiovascular status and management of patient care by medical specialists, particularly cardiologists, hypertension specialists,

The paper entitled “IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis” is prepublished online in The Journal of Immunology, the journal of The

As part of the agreement, Cephalon Australia will humanize the antibodies using their proprietary technology and conduct all development and clinical work related to the product candidate(s). In

Quintiles said that the new wholly owned facility has expanded testing capabilities with an initial focus on safety testing. The lab started receiving and testing clinical trial samples

The resubmission includes data from three consecutive manufacturing validation batches of the pegloticase active pharmaceutical ingredient (API) drug substance, additional and improved analytical methods for the control and

Both the companies are expected to collaborate on evaluating Tekmira’s stable nucleic acid-lipid particle (SNALP) technology to deliver small interfering RNA (siRNA) molecules provided by Pfizer. Under the

Under the exclusive five-year agreement, Fenwal will market and distribute the ThermoGenesis AXP AutoXpress (AXP) System and BioArchive System for use in cord blood processing and storage in

Results from the study showed that the addition of aliskiren did not provide the anticipated effect of limiting adverse changes to the heart’s left ventricle, which is the

Benson Group said that through Advanced Planning and Scheduling, it has been able to achieve a much higher utilisation of its manufacturing lines, reduced downtime between jobs and